Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access |
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc |
Journal website https://www.jocmr.org |
Original Article
Volume 15, Number 2, February 2023, pages 84-89
Quadratus Lumborum Blockade for Postoperative Analgesia in Infants and Children Following Colorectal Surgery
Figure
Tables
IQR: interquartile range; SD: standard deviation. | |
Gender, n (%) | |
Female | 83 (50.9) |
Male | 80 (49.1) |
Race, n (%) | |
Asian | 20 (12.4) |
Black | 23 (14.3) |
Hispanic | 13 (8.1) |
Other | 10 (6.2) |
White | 95 (59.0) |
Mean age, years (SD) | 4.7 (5.2) |
Median age, years (IQR) | 2.4 (0.8 - 6.7) |
Mean weight, kg (SD) | 18.6 (16.8) |
Mean height, cm (SD) | 96.3 (34.0) |
Mean body mass index (SD) | 16.9 (3.2) |
Preoperative diagnosis, n (%) | |
Chronic pain or neuropathy | 7 (4) |
Vertebral anomalies | 16 (10) |
Anorectal malformation | 68 (42) |
Chronic anticoagulation | 1 (0.6) |
Surgery type, n (%) | |
Creation/revision/closure of ostomy | 137 (84) |
Mitrofanoff/Malone | 6 (3.7) |
Herniorrhaphy | 4 (2.6) |
Transanal pull through | 4 (2.6) |
Gastrostomy tube placement | 2 (1.3) |
Other abdominal surgery | 10 (6.1) |
IQR: interquartile range; QLB: quadratus lumborum block. | |
Total number of blocks, n | 204 |
QLB laterality, n (%) | |
Bilateral | 41 (25.2) |
Unilateral | 122 (74.8) |
QLB medication, n (%) | |
0.05% ropivacaine | 1 (0.6) |
0.1% ropivacaine | 11 (6.7) |
0.2% ropivacaine | 85 (52.1) |
0.25% bupivacaine | 7 (4.3) |
0.25% ropivacaine | 2 (1.2) |
0.3% ropivacaine | 1 (0.6) |
0.5% ropivacaine | 56 (34.4) |
QLB complications noted, n (%) | |
No | 159 (100) |
QLB success, n (%) | |
No | 2 (1.2) |
Yes | 161 (98.8) |
Median procedure time, min (IQR) | 5 (4 - 9) |
Median ropivacaine dose, mg/kg (IQR) | 1.9 (1.3 - 2.6) |
Median bupivacaine dose, mg/kg (IQR) | 2.5 (2.0 - 2.6) |
Median ropivacaine volume, mL/kg (IQR) | 0.6 (0.5 - 1.0) |
Median bupivacaine volume, mL/kg (IQR) | 1.0 (0.8 - 1.0) |